TeraWulf Inc. - Common Stock (WULF)
11.56
-0.67 (-5.48%)
NASDAQ · Last Trade: Nov 20th, 11:57 PM EST
Detailed Quote
| Previous Close | 12.23 |
|---|---|
| Open | 13.44 |
| Bid | 11.58 |
| Ask | 11.61 |
| Day's Range | 11.51 - 14.75 |
| 52 Week Range | 2.060 - 17.05 |
| Volume | 74,062,574 |
| Market Cap | 2.56B |
| PE Ratio (TTM) | -8.141 |
| EPS (TTM) | -1.4 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 49,076,824 |
Chart
About TeraWulf Inc. - Common Stock (WULF)
TeraWulf Inc. is a company focused on sustainable energy solutions, specifically in the realm of cryptocurrency mining operations utilizing environmentally friendly energy sources. The firm aims to leverage renewable energy, such as solar and nuclear power, to minimize the environmental impact of its mining activities while maximizing operational efficiency. By aligning its business model with the growing demand for cryptocurrency and the need for sustainable practices, TeraWulf fosters a balance between technological advancement and ecological responsibility in the burgeoning digital asset industry. Read More
News & Press Releases
The global cryptocurrency market is currently navigating a period of profound weakness and intense volatility as of November 2025. Characterized by significant market value erosion, a prevailing sentiment of "extreme fear" among investors, and a substantial retreat from risk assets, the digital asset landscape is undergoing a critical re-evaluation. Over
Via MarketMinute · November 20, 2025
Citizens analysts assume coverage and rate IREN, Cipher, Nebius, Riot and WhiteFiber as Market Outperform.
Via Benzinga · November 20, 2025
Via Benzinga · November 20, 2025
AI data center and high-performance computing stocks climb following a blockbuster Q3 earnings report from Nvidia.
Via Benzinga · November 19, 2025
Aprea Therapeutics (Nasdaq: APRE) a clinical-stage oncology company developing next-generation cancer therapies — reported strong third-quarter progress as its lead drug programs continue to show encouraging clinical activity in multiple genetically driven cancers. The company’s precision-oncology approach targets defects in DNA damage repair (DDR) pathways including p53, WEE1, and ATR, which are common drivers of aggressive solid tumors and blood cancers such as colorectal, endometrial, ovarian, pancreatic, lung cancers, MDS, and AML .
Via AB Newswire · November 18, 2025
Via Benzinga · November 13, 2025
Via Benzinga · November 11, 2025
Shares of TeraWulf dived in early trading on Tuesday. Needham's John Todaro and Rosenblatt's Chris Brendler keep price targets.
Via Benzinga · November 11, 2025
TeraWulf reports Q3 2025 results, missing revenue estimates but showing strong strategic progress with major HPC contracts and expansion.
Via Chartmill · November 10, 2025
Here's a look at the details in TeraWulf's Q3 earnings report.
Via Benzinga · November 10, 2025
Transformational quarter marked by rapid HPC expansion, strategic growth, and long-term financings to support rapid scaling of HPC platform.
By TeraWulf Inc. · Via GlobeNewswire · November 10, 2025
Via Benzinga · November 10, 2025
Hodges Bets Heavily on Genus Sports (GENI) With an 883,376 Share Purchase
Via The Motley Fool · November 9, 2025
Hodges Capital Loads Up On 507,000 GEO Group Shares
Via The Motley Fool · November 9, 2025
On CNBC's "Mad Money Lightning Round," Jim Cramer said he likes Science Applications and recommended buying the stock.
Via Benzinga · November 4, 2025
The past 12 to 18 months have witnessed an unprecedented surge in Artificial Intelligence (AI) related deals, fundamentally reshaping the technology landscape and sending ripples across the Nasdaq and the broader financial markets. From colossal acquisitions and strategic partnerships to record-breaking funding rounds for burgeoning AI startups, capital has poured
Via MarketMinute · November 3, 2025
Via Benzinga · November 3, 2025
As October 31, 2025, draws to a close, the cryptocurrency market is grappling with a significant shift: Bitcoin (BTC) is on track to record its first monthly loss in October since 2018, shattering a seven-year streak of gains affectionately dubbed "Uptober" by market participants. This unexpected downturn, with Bitcoin's price
Via MarketMinute · October 31, 2025
Earnings Call Set for Monday, November 10 at 4:30 p.m. ET
By TeraWulf Inc. · Via GlobeNewswire · October 31, 2025
EASTON, Md., Oct. 31, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today completed its previously announced offering of 0.00% Convertible Senior Notes due 2032 (the “Convertible Notes”) in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). The aggregate principal amount of notes sold in the offering was $1.025 billion, which includes $125 million aggregate principal amount of notes issued pursuant to an option to purchase additional notes granted to the initial purchasers.
By TeraWulf Inc. · Via GlobeNewswire · October 31, 2025
EASTON, Md., Oct. 29, 2025 (GLOBE NEWSWIRE) -- TeraWulf Inc. (Nasdaq: WULF) (“TeraWulf” or the “Company”), a leading owner and operator of vertically integrated, low-carbon digital infrastructure, today announced the upsize and pricing of its offering of $900 million aggregate principal amount of 0.00% Convertible Senior Notes due 2032 (the “Convertible Notes”). The Convertible Notes will be sold in a private offering to persons reasonably believed to be qualified institutional buyers in reliance on Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”).
By TeraWulf Inc. · Via GlobeNewswire · October 29, 2025
Where does all the power for AI really come from? Find out what's happening behind the scenes as AI reshapes adjacent technology industries.
Via The Motley Fool · October 29, 2025
TeraWulf Inc.
Via Benzinga · October 29, 2025